The ratios of IL-2R/IL-6 in diabetic non-survivors at week 2 were much declined compared to that at week 1, whereas they were raised greatly in non-diabetic survivors, and there were no significant changes in the survivors with or without T2DM from week 1 to week 2. This evidence concerns the gene IL6 and type 2 diabetes mellitus.